Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.96
-0.0600-0.21%
Post-market: 27.960.00000.00%19:59 EDT
Volume:27.18M
Turnover:758.93M
Market Cap:158.97B
PE:36.80
High:28.02
Open:28.00
Low:27.77
Close:28.02
52wk High:28.75
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.85
T/O Rate:0.48%
Dividend:1.72
Dividend Rate:6.15%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.87
PE(LYR):20.49

Loading ...

CEO Bourla Says with $6-7 Bln it Has Remaining for Business Development Will be "Very Strategic"

THOMSON REUTERS
·
Aug 04

CEO Bourla Says Pfizer Has Placed Its Business Development Bets Already: Conf Call

THOMSON REUTERS
·
Aug 04

Pfizer CEO Says Company Will Maintain Dividend and Resume Dividend Growth After Loss of Exclusivity Period: Conf Call

THOMSON REUTERS
·
Aug 04

Pfizer's Non-COVID Products Show Strong Performance, Solidifying Recovery Momentum

Deep News
·
Aug 04

Pfizer Says Net Cost Savings from Now Expected to Reach $6.7 Billion Through 2029

Reuters
·
Aug 04

Headlands Research Phase 3 Trial Finds Multidose RSVpreF Vaccine Matches Single-Dose Version on Immunogenicity

Reuters
·
Aug 04

Pfizer Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Pfizer Surpasses Earnings Expectations, Driven by Strong Performance of Eliquis and Other Drugs

Deep News
·
Aug 04

Stray Alert from NYSE Tagged to Multiple Companies Withdrawn

Reuters
·
Aug 04

Dow Jones Top Company Headlines at 9 am ET: McDonald's Aims to Improve Service and Food, and Chose a New U.S. Boss to Help | Pfizer's ...

Dow Jones
·
Aug 04

Pfizer Edges up After Better-than-Expected Quarterly Results

Reuters
·
Aug 04

Coherent, Palantir, SpaceX, Caterpillar, Pfizer, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 04

Pfizer's Quarterly Results Beat Expectations on Cancer, Heart Drugs

Dow Jones
·
Aug 04

Pfizer's Mixed Q2 Results: Oncology Gains Offset COVID Revenue Declines

Deep News
·
Aug 04

Pfizer Stock (PFE) Flat on 2026 Sales Outlook as Cancer Drugs Fuel Q2 Beat

TIPRANKS
·
Aug 04

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Bloomberg
·
Aug 04

Pfizer: in 2026, NOW Expect Unfavorable Revenue Impact from Patent-Based or Regulatory Exclusivity Expiries of Approximately $1.1 Bln- SEC Filing

THOMSON REUTERS
·
Aug 04

Pfizer Logs Mixed 2Q on Oncology Growth, Covid-19 Declines

Dow Jones
·
Aug 04

Why Pfizer Stock and This Covid Vaccine Partner are Falling on Earnings

Dow Jones
·
Aug 04

Pfizer Q2 Adjusted Earnings Decline, Revenue Increases; 2026 Revenue Outlook Narrowed

MT Newswires Live
·
Aug 04